(Q42283296)

19 October 2017

title

The immune reconstitution inflammatory syndrome: a clinical update (English)

1 reference

immune reconstitution inflammatory syndrome

19 October 2017

main subject

1 reference

Wendy S Armstrong

1

1 reference

19 October 2017

publication date

1 February 2013

1 reference

Current infectious disease reports

19 October 2017

published in

1 reference

19 October 2017

volume

15

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

39-45

1 reference

Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Opportunistic infection-associated immune reconstitution syndrome in transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Immune reconstitution inflammatory syndrome: more answers, more questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Management of the immune reconstitution inflammatory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Update on immune reconstitution inflammatory syndrome: progress and unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Pathogenesis of the immune reconstitution inflammatory syndrome in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Integration of antiretroviral therapy with tuberculosis treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Mycobacterium avium complex immune reconstitution inflammatory syndrome: long term outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Effect of early versus deferred antiretroviral therapy for HIV on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Immune reconstitution inflammatory syndrome in HIV-infected patients receiving antiretroviral therapy : pathogenesis, clinical manifestations and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Dermatologic manifestations of the immune reconstitution inflammatory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11908-012-0308-Y

Recurrence of Mycobacterium avium infection in patients receiving highly active antiretroviral therapy and antimycobacterial agents

21 January 2018

1 reference

12 December 2020

Immune Reconstitution Syndrome in HIV: Validating a Case Definition and Identifying Clinical Predictors in Persons Initiating Antiretroviral Therapy

1 reference

12 December 2020

Zidovudine-induced restoration of cell-mediated immunity to mycobacteria in immunodeficient HIV-infected patients

1 reference

12 December 2020

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome: risk factors and treatment implications

1 reference

12 December 2020

Concerns regarding a randomized study of the timing of antiretroviral therapy in zimbabweans with AIDS and acute cryptococcal meningitis

1 reference

12 December 2020

Treatment of Mycobacterium avium complex immune reconstitution disease in HIV-1-infected individuals

1 reference

12 December 2020

Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

1 reference

12 December 2020

10.1007/S11908-012-0308-Y

Identifiers

DOI

1 reference

19 October 2017

1 reference